http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2013540719-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10T436-147777 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-55 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-55 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D223-16 |
| filingDate | 2011-08-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2013-11-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2013540719-A |
| titleOfInvention | Administration of lorcaserine to individuals with renal defect |
| abstract | The present disclosure relates to determining the level of normal function of an individual's kidney and to a therapeutically effective amount of (R) -8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine. Or a method of weight management in an individual in need of weight management by formulating or applying to the individual a pharmaceutically acceptable salt, solvate or hydrate thereof. However, the individual has a level of normal kidney function selected from the group consisting of absence of kidney defects, mild kidney defects, and moderate kidney defects. |
| priorityDate | 2010-09-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 21.